Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Fennec Pharmaceuticals Inc (NASDAQ: FENC) closed at $8.8 in the last session, up 3.04% from day before closing price of $8.54. In other words, the price has increased by $3.04 from its previous closing price. On the day, 80323.0 shares were traded. FENC stock price reached its highest trading level at $8.875 during the session, while it also had its lowest trading level at $8.38.
Ratios:
We take a closer look at FENC’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.97 and its Current Ratio is at 5.13.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Cantor Fitzgerald on November 22, 2022, Upgraded its rating to Overweight and sets its target price to $12 from $9 previously.
On September 07, 2022, CapitalOne started tracking the stock assigning a Overweight rating and target price of $11.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 03 ’25 when ROSTISLAV RAYKOV bought 10,000 shares for $8.61 per share.
Raykov Rosty sold 10,000 shares of FENC for $77,800 on Jun 05 ’25. The Director now owns 65,462 shares after completing the transaction at $7.78 per share. On Jun 05 ’25, another insider, ROSTISLAV RAYKOV, who serves as the Director of the company, bought 10,000 shares for $7.78 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FENC now has a Market Capitalization of 243044560 and an Enterprise Value of 225911568. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.86. Its current Enterprise Value per Revenue stands at 7.308 whereas that against EBITDA is -19.395.
Stock Price History:
The Beta on a monthly basis for FENC is 0.40, which has changed by 0.51462996 over the last 52 weeks, in comparison to a change of 0.12792087 over the same period for the S&P500. Over the past 52 weeks, FENC has reached a high of $8.72, while it has fallen to a 52-week low of $3.96. The 50-Day Moving Average of the stock is 18.67%, while the 200-Day Moving Average is calculated to be 44.34%.
Shares Statistics:
According to the various share statistics, FENC traded on average about 86.78K shares per day over the past 3-months and 87340 shares per day over the past 10 days. A total of 27.59M shares are outstanding, with a floating share count of 23.03M. Insiders hold about 16.62% of the company’s shares, while institutions hold 57.71% stake in the company. Shares short for FENC as of 1749772800 were 1364971 with a Short Ratio of 15.73, compared to 1747267200 on 1512102. Therefore, it implies a Short% of Shares Outstanding of 1364971 and a Short% of Float of 7.1499999999999995.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0